The store will not work correctly when cookies are disabled.
1-Methyl-4-phenethyl-piperazine
ID: ALA435234
PubChem CID: 12730761
Max Phase: Preclinical
Molecular Formula: C13H20N2
Molecular Weight: 204.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCN(CCc2ccccc2)CC1
Standard InChI: InChI=1S/C13H20N2/c1-14-9-11-15(12-10-14)8-7-13-5-3-2-4-6-13/h2-6H,7-12H2,1H3
Standard InChI Key: DBGWPOIRMDKCHA-UHFFFAOYSA-N
Molfile:
RDKit 2D
15 16 0 0 0 0 0 0 0 0999 V2000
-1.0833 0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1167 0.8208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6833 0.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7833 0.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7833 1.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1833 1.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1875 0.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9833 1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5833 1.3583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7167 0.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8833 1.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8833 0.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4708 1.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4833 0.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7750 1.3583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 6 1 0
3 1 1 0
4 1 1 0
5 1 1 0
6 5 1 0
7 4 1 0
8 3 1 0
9 8 1 0
10 2 1 0
11 9 2 0
12 9 1 0
13 11 1 0
14 12 2 0
15 14 1 0
2 7 1 0
15 13 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 204.32 | Molecular Weight (Monoisotopic): 204.1626 | AlogP: 1.48 | #Rotatable Bonds: 3 |
Polar Surface Area: 6.48 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.33 | CX LogP: 2.05 | CX LogD: 1.08 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.74 | Np Likeness Score: -1.09 |
References
1. Glennon RA, Salley JJ, Steinsland OS, Nelson S.. (1981) Synthesis and evaluation of novel alkylpiperazines as potential dopamine antagonists., 24 (6): [PMID:7252977] [10.1021/jm00138a007] |